Sompo Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Sompo Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-17,300	Closed	-$254K	–	153
2021 Q2	$254K	Hold	17,300	–	–	0.05%	136
2021 Q1	$212K	Buy	+17,300	New	+$222K	0.05%	130
2019 Q1	–	Sell	-15,350	Closed	-$236K	–	112
2018 Q4	$236K	Buy	+15,350	New	+$108K	0.07%	88

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sompo Asset Management's RDY Position: Q3 2021 in Review

Sompo Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2021, closing a stake of 17,300 shares — an estimated $254K sold.

Sompo Asset Management first reported a position in RDY in Q4 2018 and held it in 3 quarters. The position peaked at $254K in Q2 2021. 149 funds tracked by Wall St. Rank hold RDY as of Q3 2021.

Sompo Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2021 after selling out during the quarter.
Sompo Asset Management sold 17,300 Dr. Reddy's Laboratories shares in Q3 2021, an estimated $254K.
Sompo Asset Management first reported a position in Dr. Reddy's Laboratories in Q4 2018 and held it in 3 quarters.
Sompo Asset Management's Dr. Reddy's Laboratories position peaked at $254K in Q2 2021.
149 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2021.

Based on Sompo Asset Management's 13F filing for Q3 2021, filed 9 Nov 2021.